Alpha-lipoic acid
No studies have done using alpha-lipoic acid in the oncology population,but some evidence exists of benefit in diabetic polyneuropathy.
A meta-analysis of four trials comprising 1,258 patients with diabetic polyneuropathy demonstrated that treatment with alpha-lipoic acid (600mg/day IV) Monday through of diabetic polyneuropathy to a cliniclly mean-ingful degree